Find trending news, Grab latest news on trending and viral on social media, Breaking News, Latest News and Current News from FOXNews.com. Breaking news and video.

Saturday, 9 February 2019

2 TB survivors fight J&J monopoly bid

At present, a mere 2% of over 1.47 lakh patients suffering from multi drug resistant tuberculosis (MDR-TB) in India are currently getting Bedaquiline – a newer drug which is safer and more effective. Despite benefits of the drug, its high price remains a significant barrier for the government to make it available to all the patients enrolled with it.

from Times of India http://bit.ly/2MUxUnN
Share:

0 comments:

Post a Comment

Search This Blog

Powered by Blogger.

Arsip Blog